~~<i id='D6E6435A0F'><strike id='D6E6435A0F'><tt id='D6E6435A0F'><pre id='D6E6435A0F'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

fashion

author：focus 2025-10-01 23:06:47 - browse：6

Michel Pairet -- health business coverage from STAT — Michel Pairet Courtesy Boehringer Ingelheim

LONDON — At an event here last week, the German pharmaceutical firm Boehringer Ingelheim outlined the projects in its pipeline.

There was obesity and liver disease, and computational biology and oncology. Then respiratory and inflammatory diseases. And don’t forget mental illness and retinal health. Oh, it was also the day the company launched another Humira biosimilar.

In other words, there was a whole lot for the company to discuss as it works to promote its breadth and build partnerships with academic researchers and other companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Eat, drink, but be wary — 4 foods that interact with medications

hotspot

explore

focus

leisure time

entertainment

knowledge

0:56RussianoppositionleaderAlexeiNavalnytakespartinamarchinmemoryofslainRussianoppositionfigureBoris

WSS

Pediatricians' group reaffirms support for gender

Medical schools are missing the mark on artificial intelligence

Jesse Tyler Ferguson makes friendship bracelets for Taylor Swift's Eras Tour

Calls for Trump's election interference trial to be televised part of long debate

Walmart eyes Medicare Advantage provider ChenMed

Food makers tried to stack nutrition panel with preferred experts

leisure time

fashion

hotspot

Medicare proposal to cover medical devices draws a mixed reaction

Rock icon Freddie Mercury pre

Anesthesiologist group: stop taking Ozempic before surgery

Private equity could exacerbate cardiology's overuse problem, experts fear

Affirmative action in medical school literally saved lives

Eat, drink, but be wary — 4 foods that interact with medications

Psychedelics group wrestles with new pharma identity

Taylor Swift shares sweet moment with Kobe Bryant's daughter Bianka at Eras Tour concert

23andMe had bad news about my health. I wish a person had delivered it

Climate activists disrupt London Pride march to protest corporate sponsorship

explore

FDA proposes changes to key medical devices approval pathway

Walmart eyes Medicare Advantage provider ChenMed

Diverse clinical trials: Why aren’t we there yet?

White House touts steps to stem shortages of cancer treatments

How to make the FDA’s new prescription one

New company forms to vet health AI models, root out weaknesses

focus

leisure time

entertainment

knowledge